TAURUS DIAGNOSTICS, INC

SYRACUSE, NY · Medtech · Defunct

AI-based platform for automated prostate cancer diagnosis from MRI images using machine learning and image quality enhancement

Grants
$256K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I:AI-based system for analyzing multiparametric MRI scans for prostate lesion detection$256,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1136THEROMICS INC.—$2.3M
1137SiDx, Inc.—$2.6M
1138Cadense, Inc.—$2.1M
1139TAURUS DIAGNOSTICS, INC——
1140SFC FLUIDICS, INC.—$2.1M
1141RODO MEDICAL, INC.—$7.7M
1142BioAesthetics Corporation—$5.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.